Am J Hosp Palliat Care. 1992 Jul-Aug;9(4):11-3.

The last few days.

Abstract

In the dying patient, coma is preceded by either progressive sedation or the development of the organic brain syndrome of delirium. More than one-third of dying patients experience some difficulties during the last 48 hours of life with noisy and moist breathing, pain, and agitation and restlessness the most common. The great majority of these terminal symptoms can be managed by reassurance or drug intervention. Sublingual lorazepam and continuous subcutaneous infusion of midazolam can be effective in controlling terminal restlessness.

PMID:: 1457227; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Molecular Biology Databases

MIDAZOLAM HYDROCHLORIDE - HSDB

Supplemental Content

Related citations

Terminal restlessness--its management and the role of midazolam. [Med J Aust. 1991]
Terminal restlessness--its management and the role of midazolam.
Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA. Med J Aust. 1991 Oct 7; 155(7):485-7.
Review [Palliative sedation]. [Ned Tijdschr Geneeskd. 2005]
Review [Palliative sedation].
Verhagen EH, Hesselmann GM, Besse TC, de Graeff A. Ned Tijdschr Geneeskd. 2005 Feb 26; 149(9):458-61.
Review [Sedation in the terminal phase of life]. [Ned Tijdschr Geneeskd. 1999]
Review [Sedation in the terminal phase of life].
Verhagen EH, Eliel MR, de Graeff A, Teunissen SC. Ned Tijdschr Geneeskd. 1999 Dec 25; 143(52):2601-3.
Subcutaneous midazolam infusion in palliative care. [J Pain Symptom Manage. 1990]
Subcutaneous midazolam infusion in palliative care.
Bottomley DM, Hanks GW. J Pain Symptom Manage. 1990 Aug; 5(4):259-61.
Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. [Crit Care Med. 1996]
Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost.
Cernaianu AC, DelRossi AJ, Flum DR, Vassilidze TV, Ross SE, Cilley JH, Grosso MA, Boysen PG. Crit Care Med. 1996 Feb; 24(2):222-8.

See reviews... See all...

Cited by 1 PubMed Central article

Clinical management of dying patients. [West J Med. 1995]
Clinical management of dying patients.
Gavrin J, Chapman CR. West J Med. 1995 Sep; 163(3):268-77.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The last few days.
The last few days.
Am J Hosp Palliat Care. 1992 Jul-Aug ;9(4):11-3.

PubMed
Effects of high-intensity resistance training on bone mineral density in young m...
Effects of high-intensity resistance training on bone mineral density in young male powerlifters.
Calcif Tissue Int. 1998 Oct ;63(4):283-6.

PubMed
The highly conserved skb1 gene encodes a protein that interacts with Shk1, a fis...
The highly conserved skb1 gene encodes a protein that interacts with Shk1, a fission yeast Ste20/PAK homolog.
Proc Natl Acad Sci U S A. 1996 Nov 26 ;93(24):13802-7.

PubMed
Early onset Dressler's syndrome--a study of fifteen cases.
Early onset Dressler's syndrome--a study of fifteen cases.
Indian J Chest Dis Allied Sci. 1990 Jul-Sep ;32(3):153-6.

PubMed
Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex met...
Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web.
J Cardiovasc Pharmacol. 1992 ;20 Suppl 11:S1-16.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: